Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients
about
Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China.Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced HepatitisRadiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis
P2860
Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cost-effectiveness comparison ...... e chronic hepatitis B patients
@ast
Cost-effectiveness comparison ...... e chronic hepatitis B patients
@en
type
label
Cost-effectiveness comparison ...... e chronic hepatitis B patients
@ast
Cost-effectiveness comparison ...... e chronic hepatitis B patients
@en
prefLabel
Cost-effectiveness comparison ...... e chronic hepatitis B patients
@ast
Cost-effectiveness comparison ...... e chronic hepatitis B patients
@en
P2093
P2860
P356
P1476
Cost-effectiveness comparison ...... e chronic hepatitis B patients
@en
P2093
Shudong Zhou
Xiaohua Ye
Yanhui Gao
P2860
P304
P356
10.2147/DDDT.S98200
P407
P577
2016-03-01T00:00:00Z